share_log

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Elevance Health (纽交所:ELV) 正在经历资本回报增长
Simply Wall St ·  09/02 15:18

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. So when we looked at Elevance Health (NYSE:ELV) and its trend of ROCE, we really liked what we saw.

寻找一个有潜力大幅增长的业务并不容易,但只要我们看几个关键的财务指标就有可能。理想情况下,一个业务应该呈现出两个趋势;首先是不断增长的资本采用回报率(ROCE),其次是日益增加的资本采用量。这表明它是一个复利机器,能够不断将收益再投资到业务中并获得更高的回报。因此,当我们看到Elevance Health(NYSE:ELV)及其ROCE的趋势时,我们非常喜欢我们所看到的。

Understanding Return On Capital Employed (ROCE)

上面您可以看到蒙托克可再生能源现行ROCE与之前资本回报的比较,但过去只能知道这么多。如果您感兴趣,可以查看我们免费的蒙托克可再生能源分析师报告,了解分析师的预测。

If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. The formula for this calculation on Elevance Health is:

如果您以前没有使用过ROCE,它衡量的是公司从其业务中使用的资本所产生的“回报”(税前利润)。对于Elevance Health,这个计算公式是:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

资产雇用回报率(ROCE)是指企业利润,即企业税前利润除以企业投入的总资本(负债加股权)。如果ROCE高于企业财务成本的承受能力,那么企业就会创造出更多的价值。

0.15 = US$11b ÷ (US$113b - US$42b) (Based on the trailing twelve months to June 2024).

0.15 = US$110 billion ÷ (US$113 billion - US$42 billion)(基于截至2024年6月的过去12个月数据)。

Therefore, Elevance Health has an ROCE of 15%. On its own, that's a standard return, however it's much better than the 10% generated by the Healthcare industry.

因此,Elevance Health的ROCE为15%。单独看来,这是一个标准的回报率,但远远好于医疗保健行业的10%。

big
NYSE:ELV Return on Capital Employed September 2nd 2024
NYSE:ELV资本采用回报率于2024年9月2日

In the above chart we have measured Elevance Health's prior ROCE against its prior performance, but the future is arguably more important. If you'd like to see what analysts are forecasting going forward, you should check out our free analyst report for Elevance Health .

在上面的图表中,我们对Elevance Health的先前ROCE进行了测量,并将其与先前的业绩进行了比较,但未来可能更重要。如果您想了解分析师对未来的预测,请查看我们免费的Elevance Health分析师报告。

What The Trend Of ROCE Can Tell Us

尽管如此,当我们看 enphase energy (纳斯达克股票代码:ENPH) 的时候,它似乎并没有完全符合这些要求。

The trends we've noticed at Elevance Health are quite reassuring. The data shows that returns on capital have increased substantially over the last five years to 15%. The amount of capital employed has increased too, by 35%. The increasing returns on a growing amount of capital is common amongst multi-baggers and that's why we're impressed.

我们在Elevance Health发现的趋势相当令人 geratney。数据显示,过去五年内资本回报率大幅增长至15%。所投入的资本也增加了35%。在不断增长的资本数量上实现回报率的增加在多倍增长者中很常见,这正是我们的印象所在。

In Conclusion...

最后,同等资本下回报率较低的趋势通常不是我们关注创业板股票的最佳信号。由于这些发展进行良好,因此投资者不太可能表现友好。自五年前以来,该股下跌了32%。除非这些指标朝着更积极的轨迹转变,否则我们将继续寻找其他股票。

A company that is growing its returns on capital and can consistently reinvest in itself is a highly sought after trait, and that's what Elevance Health has. And a remarkable 136% total return over the last five years tells us that investors are expecting more good things to come in the future. Therefore, we think it would be worth your time to check if these trends are going to continue.

一家能够增加资本回报率并始终能够持续投资于自身的公司是非常受追捧的特质,而Elevance Health正具备这一特质。在过去五年内,总回报率达到了惊人的136%,这告诉我们投资者期待未来会有更多好事发生。因此,我们认为查看这些趋势是否会持续发展将是值得您花时间去做的。

While Elevance Health looks impressive, no company is worth an infinite price. The intrinsic value infographic for ELV helps visualize whether it is currently trading for a fair price.

虽然Elevance Health看起来令人印象深刻,但没有任何一家公司值得付出无限的代价。ELV的内在价值信息图可以帮助您直观地判断其当前是否以公平的价格交易。

If you want to search for solid companies with great earnings, check out this free list of companies with good balance sheets and impressive returns on equity.

如果您想寻找财务状况良好、回报卓越的实力强企业,可以免费查看以下公司列表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发